IPOs

Can This IPO Shake Up the Pharmaceutical Industry?
Can This IPO Shake Up the Pharmaceutical Industry?
Motley Fool
GoodRx
IPOs
Flag link:
Looking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO
Looking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO
Fierce Biotech
Opthea
IPOs
wet age-related macular degeneration
Flag link:
GoodRx IPO Shows Low Drug Prices Can Still Mean Big Money
GoodRx IPO Shows Low Drug Prices Can Still Mean Big Money
Forbes
drug pricing
GoodRx
IPOs
Flag link:
MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO
MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO
Pharmaforum
COMPASS Pathways
IPOs
Mind Medicine
psychedelic drugs
magic mushrooms
Flag link:
IPO, check: Now, ADC Therapeutics files for lonca approval
IPO, check: Now, ADC Therapeutics files for lonca approval
Fierce Biotech
ADC Therapeutics
IPOs
FDA
loncastuximab
diffuse large B-cell lymphoma
Flag link:
Seattle-based Athira, aiming for tough Alzheimer's and Parkinson's targets, raises $204M fo
Seattle-based Athira, aiming for tough Alzheimer's and Parkinson's targets, raises $204M fo
Endpoints
Athira Pharma
IPOs
Alzheimer's disease
Parkinson's Disease
Flag link:
Amwell raises $742M in upsized IPO
Amwell raises $742M in upsized IPO
MedCity News
IPOs
Amwell
telehealth
telemedicine
Flag link:
Biotech IPOs: Intra-Cellular Therapies, 10x Genomics and Spero Therapeutics
Biotech IPOs: Intra-Cellular Therapies, 10x Genomics and Spero Therapeutics
BioSpace
biotech
IPOs
Intra-Cellular Therapies
10x Genomics
Spero Therapeutics
Flag link:
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
NASDAQ
Vesper Healthcare Acquisition
Brent Saunders
Allergan
SPAC
IPOs
Flag link:
Codiak files for an IPO, again, this time shooting for a nine-digit raise
Codiak files for an IPO, again, this time shooting for a nine-digit raise
Endpoints
Codiak Biosciences
IPOs
Flag link:
Amwell prices IPO at $560M
Amwell prices IPO at $560M
MedCity News
Amwell
IPOs
telehealth
telemedicine
NYSE
Flag link:
Secretive, $1.6 billion liquid biopsy player Grail files IPO, revealing 2021 commercial plans
Secretive, $1.6 billion liquid biopsy player Grail files IPO, revealing 2021 commercial plans
Endpoints
Grail
liquid biopsies
IPOs
Flag link:
Oncology biotech Prelude guns for $100M IPO
Oncology biotech Prelude guns for $100M IPO
Fierce Biotech
Prelude Therapeutics
IPOs
cancer
Flag link:
With biopharma IPOs surging, GoodRx guns for $750M raise
With biopharma IPOs surging, GoodRx guns for $750M raise
Endpoints
GoodRx
IPOs
Flag link:
Will This Be the Next Big Healthcare IPO?
Will This Be the Next Big Healthcare IPO?
Motley Fool
IPOs
Amwell
Alphabet
telehealth
telemedicine
Flag link:
Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms
Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms
Endpoints
Celgene
Antengene
IPOs
startups
Jay Mei
Hong Kong
Flag link:
Portable dialysis company Outset Medical files for IPO
Portable dialysis company Outset Medical files for IPO
MedCity News
Outset Medical
dialysis
portable dialysis
devices
IPOs
Flag link:
Kymera, raising $173M+, becomes the 48th biotech IPO of the year as 2020 surpasses 2019
Kymera, raising $173M+, becomes the 48th biotech IPO of the year as 2020 surpasses 2019
Endpoints
Kymera
IPOs
NASDAQ
Flag link:
Two more biotechs leverage upsized offerings in IPO boom as Harbour pitches a raise in Hong Kong
Two more biotechs leverage upsized offerings in IPO boom as Harbour pitches a raise in Hong Kong
Endpoints
Harmony Biosciences
Inhibrx
IPOs
Flag link:
Curevac rides the Covid wave
Curevac rides the Covid wave
EP Vantage
CureVac
IPOs
vaccines
MRNA
COVID-19
Flag link:

Pages